Company Analysis

Vaxcyte, Inc. (PCVX)

Nasdaq: PCVX · Biological Products, (No Diagnostic Substances) · San Carlos, CA · filing with the SEC since 2015
Grade5.0
◀ Past 5.3● Present 6.2▶ Future 3.7
6 est.

Who runs Vaxcyte, Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Pickering Grant
CHIEF EXECUTIVE OFFICER. First filing Jun 2020, latest Sep 9, 2026, 58 filings in all.
Officers reporting now
6
of 16 people with a filing in the last fifteen months
Directors reporting now
10
26 people on the record since 2020
Officerssales are open-market, Nov 4, 2025 to Nov 4, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Wassil JimEVP, Chief Scientific Ofc, COOJun 2020Nov 4, 202623 · $3.3M
Cowan ElviaSVP, Finance & CAOJan 2023Nov 4, 20269 · $2.8M
Pickering GrantCHIEF EXECUTIVE OFFICERJun 2020Sep 9, 202619 · $3.6M
Guggenhime AndrewPRESIDENT AND CFOJun 2020Sep 9, 20265 · $1.6M
Dhaliwal Harpreet S.Chief Technical Ops OfficerOct 2021Sep 9, 20262 · $1.4M
Jodar LuisChief Medical OfficerSep 2026Sep 9, 2026none
Directorssales are open-market, Nov 4, 2025 to Nov 4, 2026
NameRoleFirst filingLatest filingSales, 12 months
Markels JohndirectorJul 2026Jul 16, 2026none
Slaoui MoncefdirectorJun 2020Jun 23, 2026none
Brandicourt OlivierdirectorMay 2025Jun 16, 2026none
Drapeau Anne SdirectorSep 2021Jun 16, 2026none
Furey JohndirectorJul 2024Jun 16, 2026none
Gilbert Halley EdirectorJun 2020Jun 16, 2026none
Lee JacksdirectorNov 2023Jun 16, 2026none
Loxam TeridirectorSep 2021Jun 16, 2026none
Lukatch HeathdirectorJun 2020Jun 16, 2026none
Paya Carlos VdirectorOct 2021Jun 16, 2026none
Earlier names on the record22, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton PCVX · research, not advice